President's Malaria Initiative

President's Malaria Initiative
U.S. Government global health program
Launch year2005
Implementing agenciesUSAID, CDC
Key officialsU.S. Global Malaria Coordinator
Focus countries24 (+ 3 programs in the Greater Mekong Subregion)
Budget$723 million (FY17)

The President's Malaria Initiative (PMI) is a U.S. Government initiative to control and eliminate malaria, one of the leading global causes of premature death and disability.[1] The initiative was originally launched by U.S. president George W. Bush in 2005, and has been continued by each successive U.S. president.[2]

PMI was originally created with a mission to "reduce malaria-related mortality by 50 percent across 15 high-burden countries in sub-Saharan Africa".[2] PMI has since expanded to 24 malaria-endemic countries in sub-Saharan Africa and 3 additional countries in the Greater Mekong Subregion of Southeast Asia, where it seeks to further reduce malaria burden and assist countries in achieving malaria elimination.[3]

PMI works closely with national malaria programs and global partners including the World Health Organization, Roll Back Malaria, and Global Fund.[4] Global malaria efforts, including those of PMI, have cut malaria mortality by over 60%, saved nearly 7 million lives, and prevented more than 1 billion malaria cases between 2000 and 2015.[5] PMI currently supports malaria prevention and control for over 500 million at-risk people in Africa.[3]

History

The U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 originally authorized the U.S. Government to provide 5 years of malaria funding to bilateral partners and the Global Fund. PMI was subsequently launched by President George W. Bush in 2005. In 2008, PMI was reauthorized for another 5 years of funding by the Lantos-Hyde Act, which also called for development of a comprehensive U.S. Global Malaria Strategy, the latest version of which is the U.S. Global Malaria Strategy 2015-2020.[6] PMI served as a major component of the Global Health Initiative, a six-year, $63-billion effort proposed by President Obama in May 2009.[7][8]

Funding

The US government, including through PMI, is currently the largest international source of financing for malaria.[3] PMI's global budget for FY2017 was $723 million.[2]

Annual PMI funding[2]
Fiscal year Budget Number of focus countries
2006 $30 million 3
2007 $154 million 7
2008 $296 million 15
2009 $300 million 15
2010 $500 million 15
2011 $578 million 19 (and the Mekong Subregion)
2012 $604 million 19 (and the Mekong Subregion)
2013 $608 million 19 (and the Mekong Subregion)
2014 $619 million 19 (and the Mekong Subregion)
2015 $619 million 19 (and the Mekong Subregion)
2016 $621 million 19 (and the Mekong Subregion)
2017 $723 million 24 (and the Mekong Subregion)

Structure and governance

PMI is interagency initiative overseen by the U.S. Global Malaria Coordinator in consultation with an Interagency Advisory Group composed of representatives from USAID, CDC, the Department of State, the Department of Defense, the National Security Council, and Office of Management and Budget. The initiative is led by USAID and implemented together with CDC. In addition to US-based staff at USAID and CDC headquarters, PMI maintains resident advisors from both agencies in each focus country.[2]

Countries

PMI currently provides direct support to 24 "focus" countries and 3 additional country programs in the Greater Mekong Subregion. At the time of its launch in 2005, PMI provided support to just three countries: Angola, Tanzania, and Uganda. Four additional countries (Malawi, Mozambique, Rwanda, and Senegal) were added the following year. By 2007, PMI had added Benin, Ethiopia, Ghana, Kenya, Liberia, Madagascar, Mali, and Zambia—bringing the total number of focus countries to the originally envisioned total of 15 high-burden nations.[2][4]

In 2010, PMI added the Democratic Republic of the Congo, Nigeria, Guinea, Zimbabwe, and the Mekong Subregion.[2]

In 2017, with additional funding from Congress, PMI expanded to 5 more countries: Burkina Faso, Cameroon, Cote d'Ivoire, Niger, and Sierra Leone.[3]

Results

PMI is estimated to have prevented 185 million malaria cases and nearly 1 million deaths between 2005 and 2017.[9] Globally, malaria mortality fell by more than 60% between 2000 and 2015. The presence of a PMI program in a country has also been associated with a significant reduction in all-cause under-5 child mortality.[10]

See also

  • PEPFAR
  • U.S. Global Malaria Coordinator

References

  1. ↑ "Can Malaria Be Eradicated?". Council on Foreign Relations. Retrieved 2018-10-13.
  2. 1 2 3 4 5 6 7 "About | PMI". President's Malaria Initiative.
  3. 1 2 3 4 "The President's Malaria Initiative, 12th Annual Report to Congress" (PDF). PMI.gov.
  4. 1 2 Loewenberg, Samuel (2007-12-08). "The US President's Malaria Initiative: 2 years on". The Lancet. 370 (9603): 1893–1894. doi:10.1016/S0140-6736(07)61795-4. ISSN 0140-6736. PMID 18074434.
  5. ↑ "WHO | World malaria report". WHO. Archived from the original on April 16, 2013. Retrieved 2018-10-13.
  6. ↑ "The President's Malaria Initiative and Other U.S. Government Global Malaria Efforts". The Henry J. Kaiser Family Foundation. 2018-04-10. Retrieved 2018-10-13.
  7. ↑ "The U.S. Global Health Initiative: Overview & Budget Analysis". The Henry J. Kaiser Family Foundation. 2009-11-29. Retrieved 2018-10-13.
  8. ↑ Global Health Technical Assistance Project (2011). "External evaluation of the President's Malaria Initiative: final report" (PDF).
  9. ↑ Winskill, Peter; Slater, Hannah C.; Griffin, Jamie T.; Ghani, Azra C.; Walker, Patrick G. T. (2017-11-21). "The US President's Malaria Initiative, Plasmodium falciparum transmission and mortality: A modelling study". PLOS Medicine. 14 (11): e1002448. doi:10.1371/journal.pmed.1002448. ISSN 1549-1676. PMC 5697814. PMID 29161259.
  10. ↑ Jakubowski, Aleksandra; Stearns, Sally C.; Kruk, Margaret E.; Angeles, Gustavo; Thirumurthy, Harsha (2017-06-13). "The US President's Malaria Initiative and under-5 child mortality in sub-Saharan Africa: A difference-in-differences analysis". PLOS Medicine. 14 (6): e1002319. doi:10.1371/journal.pmed.1002319. ISSN 1549-1676. PMC 5469567. PMID 28609442.

More sources

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.